GE HealthCare Technologies Inc. $GEHC Shares Sold by Eagle Rock Investment Company LLC

Eagle Rock Investment Company LLC decreased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 50.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,262 shares of the company’s stock after selling 29,405 shares during the period. Eagle Rock Investment Company LLC’s holdings in GE HealthCare Technologies were worth $2,400,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. E Fund Management Hong Kong Co. Ltd. grew its stake in GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after buying an additional 196 shares during the last quarter. Godsey & Gibb Inc. bought a new stake in GE HealthCare Technologies in the third quarter valued at $26,000. Oakworth Capital Inc. boosted its holdings in shares of GE HealthCare Technologies by 1,876.2% during the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after acquiring an additional 394 shares during the period. Piscataqua Savings Bank boosted its holdings in shares of GE HealthCare Technologies by 173.4% during the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after acquiring an additional 300 shares during the period. Finally, Salomon & Ludwin LLC grew its position in shares of GE HealthCare Technologies by 326.5% during the third quarter. Salomon & Ludwin LLC now owns 482 shares of the company’s stock worth $37,000 after acquiring an additional 369 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on GEHC shares. Citigroup dropped their price objective on shares of GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a report on Wednesday, March 11th. The Goldman Sachs Group reissued a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Stifel Nicolaus upped their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Finally, Evercore lifted their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $69.23 on Friday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $89.77. The stock’s fifty day moving average is $77.91 and its 200-day moving average is $78.26. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The firm has a market capitalization of $31.59 billion, a price-to-earnings ratio of 15.18, a price-to-earnings-growth ratio of 1.57 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is currently 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.